Type 2 diabetes with chronic kidney disease — USMLE Step 3 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Add an SGLT2 inhibitor
SGLT2 inhibitors reduce kidney and cardiovascular events in patients with type 2 diabetes and albuminuric chronic kidney disease, independent of modest glycemic effects.
Reference: ADA Standards of Care in Diabetes 2026